|
advertisement
|
|
|
| Journal Articles Details
|
| Pharmacogenomics Journals |
| Clin Chem. 06 2004;50(9):1623-33 |
Allele-specific change of concentration and functional gene dose for the prediction of steady-state serum concentrations of amitriptyline and nortriptyline in CYP2C19 and CYP2D6 extensive and intermediate metabolizers. |
Steimer W, Zöpf K, von Amelunxen S, Pfeiffer H, Bachofer J, Popp J, Messner B, Kissling W, Leucht S.
Institut für Klinische Chemie und Pathobiochemie, Technische Universität München, Munich, Germany. Steimer@KlinChem.med.TU-Muenchen.de |
Publication Date: Friday, August 27, 2004
|
Click here to view MEDLINE citation |
|
More August, 2004 pharmacogenomics journal articles.- The role of pharmacogenetics in future practice.
by Carey L.
Journal: JAAPA. 17(7):31-2, 47
- UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer.
by Marcuello E, Altés A, Menoyo A, Del Rio E, Gómez-Pardo M, Baiget M.
Journal: Br J Cancer. 91(4):678-82
- [Pharmacogenomics: from genes to drug sensitivity]
by Loriot MA, Beaune P.
Journal: Med Sci (Paris). 2004 Jun-Jul;20(6-7):634-6
- Adverse drug reactions (ADRs) in children: Part 1.
by Kanneh AB.
Journal: Paediatr Nurs. 2004 Jul-Aug;16(6):32-5
- Genome-wide discovery of loci influencing chemotherapy cytotoxicity.
by Watters JW, Kraja A, Meucci MA, Province MA, McLeod HL.
Journal: Proc Natl Acad Sci U S A. 07 2004;101(32):11809-14
- Thiopurine methyltransferase: should it be measured before commencing thiopurine drug therapy?
by Sanderson J, Ansari A, Marinaki T, Duley J.
Journal: Ann Clin Biochem. 41(Pt 4):294-302
- Caution with beta1-adrenergic receptor genotyping.
by Lanfear DE, Marsh S, McLeod HL.
Journal: Clin Pharmacol Ther. 76(2):185-6; author reply 186
- Genetic variability in cytochrome P450 3A5 and in vivo cytochrome P450 3A activity: some answers but still questions.
by Wilkinson GR.
Journal: Clin Pharmacol Ther. 76(2):99-103
- Microarrays: new pharmacogenomic tools for the twenty-first century.
by Sweeney BP.
Journal: Eur J Anaesthesiol. 21(7):505-8
- Report on the joint EFPIA, DIA and EMEA pharmacogenetics workshop: moving toward clinical application.
by McCarthy A, Kerr M, Abadie E, Chibout SD, Imbert G, Cohen N, Drakoulis N, Knudsen LE, Flamion B, Hashimoto L, Kreutz WV, McHale D, Mitchell T, Papaluca Amati M, Roberts R, Shaw P, Stuerzebecher CS, Townend D.
Journal: Pharmacogenomics. 5(6):731-9
- Pharmacogenomics. Cancer sharpshooters rely on DNA tests for a better aim.
by Couzin J.
Journal: Science. 305(5688):1222-3
- Functional impact of CYP2C95, CYP2C96, CYP2C98, and CYP2C911 in vivo among black Africans.
by Allabi AC, Gala JL, Horsmans Y, Babaoglu MO, Bozkurt A, Heusterspreute M, Yasar U.
Journal: Clin Pharmacol Ther. 76(2):113-8
- Breed distribution and history of canine mdr1-1Delta, a pharmacogenetic mutation that marks the emergence of breeds from the collie lineage.
by Neff MW, Robertson KR, Wong AK, Safra N, Broman KW, Slatkin M, Mealey KL, Pedersen NC.
Journal: Proc Natl Acad Sci U S A. 08 2004;101(32):11725-30
- The drugs don't work: pharmacogenomics--clinical biochemistry's future?
by Hallworth MJ.
Journal: Ann Clin Biochem. 41(Pt 4):260-2
- Neuropsychiatric complications of medical and surgical therapies for Parkinson's disease.
by Burn DJ, Tröster AI.
Journal: J Geriatr Psychiatry Neurol. 17(3):172-80
- Rapid, long-range molecular haplotyping of thiopurine S-methyltransferase (TPMT) *3A, *3B, and *3C.
by von Ahsen N, Armstrong VW, Oellerich M.
Journal: Clin Chem. 07 2004;50(9):1528-34
- The contribution of a novel ribosomal S12 mutation to aminoglycoside resistance of Escherichia coli mutants.
by Gill AE, Amyes SG.
Journal: J Chemother. 16(4):347-9
- Pharmacogenetics of antipsychotic-induced weight gain.
by Correll CU, Malhotra AK.
Journal: Psychopharmacology (Berl). 07 2004;174(4):477-89
- Mining our ABCs: pharmacogenomic approach for evaluating transporter function in cancer drug resistance.
by Ross DD, Doyle LA.
Journal: Cancer Cell. 6(2):105-7
- Impact of polymorphisms of cytochrome-P450 isoenzymes 2C9, 2C19 and 2D6 on plasma concentrations and clinical effects of antidepressants in a naturalistic clinical setting.
by Grasmäder K, Verwohlt PL, Rietschel M, Dragicevic A, Müller M, Hiemke C, Freymann N, Zobel A, Maier W, Rao ML.
Journal: Eur J Clin Pharmacol. 05 2004;60(5):329-36
More pharmacogenomics journal articles ... |
Journal Articles Categories:
Health Informatics Journal Articles |
Telemedicine Journal Articles |
Hospital Information Systems Journal Articles |
Data Protection and Privacy Journals Articles |
Mobile and Wireless Computing Journal Articles |
Medical Decision Making |
Bioinformatics Journal Articles |
Genomics Journal Articles |
Proteomics Journal Articles |
Pharmacogenomics Journal Articles
|